Diabetes News

ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.

A set of newly identified genetic risk factors tied to the development of type 2 diabetes could eventually lead to the discovery of genotypes that allow providers to identify people at highest risk for complications.

Insulin out-of-pocket caps were associated with reduced insulin costs but not increased insulin use, according to a study published in the Annals of Internal Medicine.

Using an electronic health record algorithm and practice facilitators in primary care did not reduce hospitalizations in adults with chronic kidney disease, type 2 diabetes and hypertension, according to results of a study.

ATLANTA — Adults with obesity, HF with preserved ejection fraction and type 2 diabetes saw marked improvements in HF symptoms and physical function with semaglutide 2.4 mg compared with placebo, despite less than typical weight loss.

The impact of social determinants of health on cardiovascular risk factors may vary across Asian American subgroups such as Filipino, Asian Indian, Chinese and other Asian populations, researchers reported.

Adults with type 2 diabetes have a reduction in overall health care costs after bariatric surgery, regardless of whether they underwent gastric bypass or sleeve gastrectomy, according to study findings published in Obesity.

Prices for most diabetes medications exceed their manufacturing costs, and the addition of generic or biosimilar medications could help to lower prices, according to study findings published in JAMA Network Open.

Intensive lifestyle intervention did not significantly change eGFR slope during 10 years in patients with type 2 diabetes and preserved kidney function, researchers found in a study.